Role	O
of	O
ascorbate	O
in	O
the	O
activation	O
of	O
NF-kappaB	B-protein
by	O
tumour	B-protein
necrosis	I-protein
factor-alpha	I-protein
in	O
T-cells	B-cell_type
.	O

The	O
first	O
product	O
of	O
ascorbate	O
oxidation	O
,	O
the	O
ascorbate	O
free	O
radical	O
(	O
AFR	O
)	O
,	O
acts	O
in	O
biological	O
systems	O
mainly	O
as	O
an	O
oxidant	O
,	O
and	O
through	O
its	O
role	O
in	O
the	O
plasma	O
membrane	O
redox	O
system	O
exerts	O
different	O
effects	O
on	O
the	O
cell	O
.	O

We	O
have	O
investigated	O
the	O
role	O
of	O
ascorbate	O
,	O
AFR	O
and	O
dehydroascorbate	O
(	O
DHA	O
)	O
in	O
the	O
activation	O
of	O
the	O
NF-kappaB	B-protein
transcription	I-protein
factor	I-protein
in	O
Jurkat	B-cell_line
T-cells	I-cell_line
stimulated	O
by	O
tumour	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
.	O

Here	O
we	O
show	O
,	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
that	O
ascorbate	O
increases	O
the	O
binding	O
of	O
NF-kappaB	B-protein
to	O
DNA	O
in	O
TNF-alpha-stimulated	B-cell_line
Jurkat	I-cell_line
cells	I-cell_line
.	O

The	O
ability	O
of	O
ascorbate	O
to	O
enhance	O
cytoplasmic	O
inhibitory	O
IkBalpha	B-protein
protein	I-protein
degradation	O
correlates	O
completely	O
with	O
its	O
capacity	O
to	O
induce	O
NF-kappaB	B-protein
binding	O
to	O
DNA	O
and	O
to	O
potentiate	O
NF-kappaB	B-protein
-mediated	O
transactivation	O
of	O
the	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
promoter	I-DNA
in	O
TNF-alpha-stimulated	B-cell_line
Jurkat	I-cell_line
cells	I-cell_line
but	O
not	O
in	O
cells	O
stimulated	O
with	O
PMA	O
plus	O
ionomycin	O
.	O

AFR	O
behaves	O
like	O
ascorbate	O
,	O
while	O
DHA	O
and	O
ascorbate	O
phosphate	O
do	O
not	O
affect	O
TNF-alpha	B-protein
-mediated	O
NF-kappaB	B-protein
activation	O
.	O

These	O
results	O
provide	O
new	O
evidence	O
for	O
a	O
possible	O
relationship	O
between	O
the	O
activation	O
of	O
the	O
electron-transport	O
system	O
at	O
the	O
plasma	O
membrane	O
by	O
ascorbate	O
or	O
its	O
free	O
radical	O
and	O
redox-dependent	O
gene	O
transcription	O
in	O
T-cells	B-cell_type
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
325	NULL
,	NULL
23-28	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
23	NULL
Role	NULL
of	NULL
ascorbate	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
tumour	NULL
necrosis	NULL
factor-a	NULL
in	NULL
T-cells	NULL
Eduardo	NULL
MUNOZ*f§	NULL
,	NULL
M.	NULL
Valle	NULL
BLAZQUEZ*f	NULL
,	NULL
Carmen	NULL
ORTIZ*	NULL
,	NULL
Consuelo	NULL
GOMEZ-DIAZt	NULL
and	NULL
Placido	NULL
NAVASt	NULL
*Departamento	NULL
de	NULL
Fisiologia	NULL
e	NULL
Inmunologia	NULL
,	NULL
Facultad	NULL
de	NULL
Medicina	NULL
,	NULL
Universidad	NULL
de	NULL
Cordoba	NULL
,	NULL
Avda	NULL
.	NULL

Menendez	NULL
Pidal	NULL
s/n	NULL
,	NULL
14071	NULL
Cordoba	NULL
,	NULL
Spain	NULL
,	NULL
and	NULL
$	NULL
Departamento	NULL
de	NULL
Biologia	NULL
Celular	NULL
,	NULL
Facultad	NULL
de	NULL
Ciencias	NULL
,	NULL
Universidad	NULL
de	NULL
Cordoba	NULL
,	NULL
Avda	NULL
.	NULL

Menendez	NULL
Pidal	NULL
s/n	NULL
,	NULL
14071	NULL
Cordoba	NULL
,	NULL
Spain	NULL
The	NULL
first	NULL
product	NULL
of	NULL
ascorbate	NULL
oxidation	NULL
,	NULL
the	NULL
ascorbate	NULL
free	NULL
radical	NULL
(	NULL
AFR	NULL
)	NULL
,	NULL
acts	NULL
in	NULL
biological	NULL
systems	NULL
mainly	NULL
as	NULL
an	NULL
oxidant	NULL
,	NULL
and	NULL
through	NULL
its	NULL
role	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
redox	NULL
system	NULL
exerts	NULL
different	NULL
effects	NULL
on	NULL
the	NULL
cell	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
ascorbate	NULL
,	NULL
AFR	NULL
and	NULL
dehydroascorbate	NULL
(	NULL
DHA	NULL
)	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
stimulated	NULL
by	NULL
tumour	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
,	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
that	NULL
ascorbate	NULL
increases	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
DNA	NULL
in	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
ascorbate	NULL
to	NULL
enhance	NULL
cytoplasmic	NULL
inhibitory	NULL
IkBa	NULL
protein	NULL
degradation	NULL
correlates	NULL
completely	NULL
with	NULL
its	NULL
capacity	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
DNA	NULL
and	NULL
to	NULL
potentiate	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
promoter	NULL
in	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

AFR	NULL
behaves	NULL
like	NULL
ascorbate	NULL
,	NULL
while	NULL
DHA	NULL
and	NULL
ascorbate	NULL
phosphate	NULL
do	NULL
not	NULL
affect	NULL
TNF-a-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
new	NULL
evidence	NULL
for	NULL
a	NULL
possible	NULL
relationship	NULL
between	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
electron-transport	NULL
system	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
by	NULL
ascorbate	NULL
or	NULL
its	NULL
free	NULL
radical	NULL
and	NULL
redox-dependent	NULL
gene	NULL
transcription	NULL
in	NULL
T-cells	NULL
.	NULL

INTRODUCTION	NULL
Cell	NULL
plasma	NULL
membrane	NULL
contains	NULL
an	NULL
electron-transport	NULL
chain	NULL
which	NULL
is	NULL
essential	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
[	NULL
1	NULL
]	NULL
.	NULL

Ascorbate	NULL
is	NULL
a	NULL
redox	NULL
active	NULL
compound	NULL
that	NULL
by	NULL
two	NULL
one-electron	NULL
reduction	NULL
steps	NULL
acts	NULL
as	NULL
an	NULL
antioxidant	NULL
to	NULL
prevent	NULL
lipid	NULL
peroxidation	NULL
by	NULL
quenching	NULL
oxygen-derived	NULL
radicals	NULL
or	NULL
regenerating	NULL
the	NULL
lipophilic	NULL
antioxidant	NULL
a-tocopherol	NULL
[	NULL
2	NULL
]	NULL
.	NULL

The	NULL
first	NULL
product	NULL
of	NULL
ascorbate	NULL
oxidation	NULL
,	NULL
the	NULL
ascorbate	NULL
free	NULL
radical	NULL
(	NULL
AFR	NULL
)	NULL
,	NULL
acts	NULL
mainly	NULL
as	NULL
an	NULL
oxidant	NULL
in	NULL
the	NULL
cell	NULL
system	NULL
and	NULL
is	NULL
reduced	NULL
to	NULL
ascorbate	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
by	NULL
the	NULL
coenzyme	NULL
Q-dependent	NULL
NADH	NULL
:	NULL
AFR	NULL
reductase	NULL
[	NULL
3	NULL
]	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
regeneration	NULL
of	NULL
ascorbate	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
[	NULL
4,5	NULL
]	NULL
.	NULL

This	NULL
cycle	NULL
of	NULL
ascorbate/AFR	NULL
is	NULL
maintained	NULL
by	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
[	NULL
6,7	NULL
]	NULL
and	NULL
participates	NULL
in	NULL
the	NULL
potentiation	NULL
of	NULL
plasma-membrane-dependent	NULL
mechanisms	NULL
to	NULL
control	NULL
cell	NULL
growth	NULL
[	NULL
8	NULL
]	NULL
.	NULL

In	NULL
recent	NULL
years	NULL
,	NULL
emerging	NULL
evidence	NULL
suggests	NULL
an	NULL
important	NULL
role	NULL
for	NULL
this	NULL
vitamin	NULL
in	NULL
cell	NULL
growth	NULL
[	NULL
8,9	NULL
]	NULL
.	NULL

Ascorbate	NULL
increases	NULL
the	NULL
mitogen	NULL
response	NULL
of	NULL
human	NULL
peripheral	NULL
lymphocytes	NULL
to	NULL
lectins	NULL
[	NULL
10	NULL
]	NULL
and	NULL
human	NULL
promyelocytic	NULL
cell	NULL
growth	NULL
in	NULL
serum-limiting	NULL
media	NULL
[	NULL
11	NULL
]	NULL
,	NULL
and	NULL
also	NULL
induces	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
neuro-ectodermal	NULL
and	NULL
melanoma	NULL
cells	NULL
[	NULL
12	NULL
]	NULL
.	NULL

Although	NULL
the	NULL
mechanisms	NULL
used	NULL
by	NULL
external	NULL
oxidants	NULL
in	NULL
order	NULL
to	NULL
regulate	NULL
cell	NULL
growth	NULL
are	NULL
largely	NULL
unknown	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
they	NULL
modulate	NULL
cell	NULL
signalling	NULL
and/or	NULL
the	NULL
activity	NULL
of	NULL
some	NULL
transcription	NULL
factors	NULL
.	NULL

Among	NULL
those	NULL
transcription	NULL
factors	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
one	NULL
of	NULL
the	NULL
more	NULL
extensively	NULL
studied	NULL
.	NULL

This	NULL
factor	NULL
,	NULL
formerly	NULL
described	NULL
as	NULL
a	NULL
kappa	NULL
enhancer	NULL
binding	NULL
transcription	NULL
factor	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
mature	NULL
B-cells	NULL
[	NULL
13	NULL
]	NULL
,	NULL
is	NULL
part	NULL
of	NULL
a	NULL
pleiotropic	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
many	NULL
cellular	NULL
genes	NULL
whose	NULL
products	NULL
participate	NULL
in	NULL
the	NULL
mechanisms	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
also	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
determinated	NULL
viral	NULL
genes	NULL
[	NULL
14,15	NULL
]	NULL
.	NULL

In	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
found	NULL
in	NULL
an	NULL
inactive	NULL
cytosolic	NULL
form	NULL
,	NULL
retained	NULL
by	NULL
association	NULL
with	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB	NULL
[	NULL
14,15	NULL
]	NULL
.	NULL

Upon	NULL
cell	NULL
activation	NULL
by	NULL
phorbol	NULL
esters	NULL
,	NULL
mitogens	NULL
,	NULL
cytokines	NULL
,	NULL
UV	NULL
and	NULL
viral	NULL
proteins	NULL
,	NULL
IkB	NULL
undergoes	NULL
rapid	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
,	NULL
then	NULL
releasing	NULL
the	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
to	NULL
the	NULL
nucleus	NULL
[	NULL
16,17	NULL
]	NULL
.	NULL

It	NULL
is	NULL
assumed	NULL
that	NULL
redox	NULL
reactions	NULL
may	NULL
be	NULL
mediators	NULL
of	NULL
different	NULL
activating	NULL
signals	NULL
[	NULL
18	NULL
]	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
exogenous	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
some	NULL
types	NULL
of	NULL
cells	NULL
[	NULL
19	NULL
]	NULL
,	NULL
and	NULL
protein	NULL
phosphorylation	NULL
is	NULL
known	NULL
to	NULL
be	NULL
increased	NULL
after	NULL
the	NULL
action	NULL
of	NULL
extracellular	NULL
oxidants	NULL
in	NULL
T-cells	NULL
[	NULL
20	NULL
]	NULL
.	NULL

Also	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
different	NULL
stimuli	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
antioxidant	NULL
thiols	NULL
or	NULL
iron	NULL
chelators	NULL
by	NULL
preventing	NULL
IxBa	NULL
phosphorylation	NULL
[	NULL
21	NULL
]	NULL
,	NULL
a	NULL
process	NULL
that	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
the	NULL
IxBa	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
[	NULL
22,23	NULL
]	NULL
.	NULL

We	NULL
show	NULL
here	NULL
the	NULL
role	NULL
of	NULL
ascorbate	NULL
in	NULL
the	NULL
mechanisms	NULL
activated	NULL
by	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-a	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Ascorbate	NULL
and	NULL
its	NULL
free	NULL
radical	NULL
potentiate	NULL
IxBa	NULL
degradation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
and	NULL
consequently	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
HIV-LTR	NULL
)	NULL
gene	NULL
transactivation	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
activation	NULL
leads	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
growth	NULL
.	NULL

We	NULL
discuss	NULL
our	NULL
data	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
action	NULL
of	NULL
ascorbate	NULL
through	NULL
its	NULL
free	NULL
radical	NULL
which	NULL
,	NULL
as	NULL
an	NULL
oxidant	NULL
,	NULL
activates	NULL
the	NULL
plasma	NULL
membrane	NULL
electron	NULL
transport	NULL
and	NULL
leads	NULL
to	NULL
the	NULL
redox-dependent	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
reagents	NULL
The	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

The	NULL
5.1	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
N.	NULL
Israél	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
and	NULL
J-170	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
A.	NULL
Corbi	NULL
,	NULL
C.S.1.C	NULL
.	NULL

,	NULL
Granada	NULL
,	NULL
Spain	NULL
)	NULL
cell	NULL
lines	NULL
Abbreviations	NULL
used	NULL
:	NULL
AFR	NULL
,	NULL
ascorbate	NULL
free	NULL
radical	NULL
;	NULL
DHA	NULL
,	NULL
dehydroascorbate	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
TNF-a	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

{	NULL
E.	NULL
M.	NULL
and	NULL
M.	NULL
V.	NULL
B.	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

24	NULL
E.	NULL
Mufoz	NULL
and	NULL
others	NULL
are	NULL
Jurkat-derived	NULL
clones	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-LTR	NULL
or	NULL
the	NULL
CD11a	NULL
promoter-derived	NULL
luciferase	NULL
gene	NULL
respectively	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
exponential	NULL
growth	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal-calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
and	NULL
penicillin/	NULL
streptomycin	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
air/CO	NULL
,	NULL
(	NULL
19:1	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
5.1	NULL
and	NULL
J-170	NULL
cells	NULL
were	NULL
always	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
geneticin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
ascorbate	NULL
,	NULL
dehydroascorbate	NULL
(	NULL
DHA	NULL
)	NULL
and	NULL
superoxide	NULL
dismutase	NULL
were	NULL
all	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
Deisenhofen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Ascorbate	NULL
phosphate	NULL
was	NULL
obtained	NULL
from	NULL
Dr.	NULL
D.	NULL
J.	NULL
Morré	NULL
(	NULL
Purdue	NULL
University	NULL
,	NULL
West	NULL
Lafayette	NULL
,	NULL
IN	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

[	NULL
methy	NULL
!	NULL

-*H	NULL
]	NULL
Thymidine	NULL
(	NULL
68	NULL
Ci/mmol	NULL
)	NULL
was	NULL
from	NULL
ICN	NULL
(	NULL
Irvine	NULL
,	NULL
CA	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

AFR	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
mixture	NULL
of	NULL
ascorbate	NULL
and	NULL
DHA	NULL
at	NULL
equimolar	NULL
concentration	NULL
in	NULL
distilled	NULL
water	NULL
,	NULL
adjusted	NULL
to	NULL
pH	NULL
6.5	NULL
with	NULL
1	NULL
M	NULL
imidazole	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
[	NULL
11	NULL
]	NULL
.	NULL

Cell	NULL
extracts	NULL
and	NULL
mobility	NULL
shift	NULL
assays	NULL
Jurkat	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
and	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
0.2	NULL
mM	NULL
ascorbate	NULL
or	NULL
its	NULL
derived	NULL
products	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
then	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
.	NULL

Cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
[	NULL
24	NULL
]	NULL
.	NULL

For	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
located	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
the	NULL
H-2°	NULL
promoter	NULL
was	NULL
used	NULL
(	NULL
KBF	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
mixture	NULL
contained	NULL
10	NULL
ug	NULL
of	NULL
protein	NULL
extracts	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.01	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Nonidet	NULL
P40	NULL
,	NULL
100	NULL
ug/ml	NULL
BSA	NULL
,	NULL
4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Ficoll	NULL
and	NULL
100000	NULL
c.p.m	NULL
.	NULL

of	NULL
end-labelled	NULL
DNA	NULL
fragments	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
wl	NULL
.	NULL

After	NULL
30	NULL
min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
electrophoresed	NULL
through	NULL
a	NULL
6	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
non-denaturing	NULL
conditions	NULL
and	NULL
subsequently	NULL
dried	NULL
and	NULL
exposed	NULL
at	NULL
-80	NULL
°C	NULL
to	NULL
XAR	NULL
film	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
preimmune	NULL
serum	NULL
or	NULL
specific	NULL
antiserum	NULL
anti-p50	NULL
(	NULL
0.5	NULL
ul	NULL
)	NULL
was	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabelled	NULL
probe	NULL
.	NULL

Western	NULL
blots	NULL
Proteins	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
were	NULL
boiled	NULL
in	NULL
Laemmli	NULL
buffer	NULL
and	NULL
electrophoresed	NULL
in	NULL
denaturing	NULL
SDS/polyacrylamide	NULL
(	NULL
12	NULL
%	NULL
)	NULL
gels	NULL
.	NULL

Separated	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
and	NULL
immunodetection	NULL
of	NULL
IxBa	NULL
protein	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
anti-	NULL
{	NULL
(	NULL
MAD-3	NULL
)	NULL
monoclonal	NULL
antibody	NULL
10B	NULL
,	NULL
given	NULL
by	NULL
Drs	NULL
.	NULL

K.	NULL
Wood	NULL
and	NULL
R.T.	NULL
Hay	NULL
(	NULL
St.	NULL
Andrews	NULL
,	NULL
Fife	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Immunodetection	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
specific	NULL
anti-p50	NULL
antiserum	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Israél	NULL
(	NULL
Institute	NULL
Pasteur	NULL
)	NULL
.	NULL

Proteins	NULL
detected	NULL
by	NULL
the	NULL
primary	NULL
antibody	NULL
were	NULL
visualized	NULL
with	NULL
the	NULL
use	NULL
of	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Amersham	NULL
,	NULL
Bucks	NULL
.	NULL

,	NULL
U.K.	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
and	NULL
luciferase	NULL
activity	NULL
Jurkat	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
apparatus	NULL
)	NULL
at	NULL
150	NULL
V/960	NULL
uF	NULL
a	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
following	NULL
plasmids	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
(	NULL
«	NULL
B	NULL
)	NULL
x3-conaluc	NULL
plasmid	NULL
that	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
MHC	NULL
enhancer	NULL
«	NULL
B	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
conalbumin	NULL
promoter	NULL
followed	NULL
by	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
KBF-Luc	NULL
)	NULL
;	NULL
(	NULL
2	NULL
)	NULL
the	NULL
HIV-LTR	NULL
plasmid	NULL
followed	NULL
by	NULL
the	NULL
luciferase	NULL
gene	NULL
;	NULL
and	NULL
(	NULL
3	NULL
)	NULL
the	NULL
AHIV-LTR	NULL
mutated	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
given	NULL
by	NULL
Dr.	NULL
A.	NULL
Garcia	NULL
,	NULL
Institut	NULL
Pasteur	NULL
)	NULL
.	NULL

Transfected	NULL
Jurkat	NULL
,	NULL
J-170	NULL
or	NULL
5.1	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
25	NULL
mM	NULL
Tris/phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
8	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Triton	NULL
X-100	NULL
and	NULL
15	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
Berthold	NULL
)	NULL
.	NULL

The	NULL
background	NULL
obtained	NULL
with	NULL
the	NULL
lysis	NULL
buffer	NULL
was	NULL
subtracted	NULL
from	NULL
each	NULL
experimental	NULL
value	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
and	NULL
the	NULL
mean	NULL
RLU	NULL
(	NULL
relative	NULL
light	NULL
unit	NULL
)	NULL
values	NULL
were	NULL
calculated	NULL
.	NULL

All	NULL
the	NULL
experiments	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
analysis	NULL
of	NULL
variance	NULL
followed	NULL
by	NULL
the	NULL
Stud-ent-Newman-Keuls	NULL
method	NULL
with	NULL
values	NULL
of	NULL
P	NULL
<	NULL
0.05	NULL
considered	NULL
to	NULL
be	NULL
significant	NULL
.	NULL

Proliferation	NULL
assays	NULL
Jurkat	NULL
cells	NULL
(	NULL
2.5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
96-well	NULL
microtitre	NULL
plate	NULL
(	NULL
200	NULL
ul/well	NULL
)	NULL
in	NULL
complete	NULL
RPMI-1640	NULL
medium	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
different	NULL
doses	NULL
of	NULL
TNF-a	NULL
with	NULL
or	NULL
without	NULL
0.2	NULL
mM	NULL
ascorbate	NULL
.	NULL

Proliferation	NULL
was	NULL
measured	NULL
by	NULL
[	NULL
*HJthymidine	NULL
incorporation	NULL
(	NULL
0.5	NULL
wCi/well	NULL
)	NULL
for	NULL
the	NULL
last	NULL
6h	NULL
of	NULL
a	NULL
48-h	NULL
culture	NULL
period	NULL
.	NULL

Radioactivity	NULL
incorporated	NULL
into	NULL
DNA	NULL
was	NULL
measured	NULL
by	NULL
liquid-scintillation	NULL
counting	NULL
and	NULL
specific	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
d.p.m./10®	NULL
cells	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
To	NULL
study	NULL
the	NULL
role	NULL
of	NULL
ascorbate	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
we	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
a	NULL
T	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
with	NULL
TNF-a	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
for	NULL
60	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
0.2	NULL
mM	NULL
ascorbate	NULL
,	NULL
a	NULL
concentration	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
optimal	NULL
to	NULL
stimulate	NULL
growth	NULL
and	NULL
differentiation	NULL
induced	NULL
by	NULL
hapten	NULL
stimuli	NULL
[	NULL
25	NULL
]	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
and	NULL
analysed	NULL
by	NULL
EMSA	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B-specific	NULL
**P-la	NULL
belled	NULL
oligonucleotide	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
(	NULL
left	NULL
)	NULL
,	NULL
ascorbate	NULL
mediated	NULL
a	NULL
clear	NULL
increase	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
induced	NULL
by	NULL
TNF-	NULL
«	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
the	NULL
ascorbate	NULL
effect	NULL
was	NULL
less	NULL
evident	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
was	NULL
$	NULL
+4	NULL
©	NULL
~	NULL
r	NULL
q	NULL
x	NULL
a	NULL
s	NULL
:	NULL
a	NULL
%	NULL
Competitor	NULL
:	NULL
-	NULL
m	NULL
%	NULL
%	NULL
-	NULL
``	NULL
ill	NULL
'	NULL
>	NULL
%	NULL
&	NULL
s	NULL
ib	NULL
t	NULL
B	NULL
E	NULL
Abi	NULL
_-	NULL
-	NULL
--	NULL
#	NULL
&	NULL
e	NULL
-	NULL
NF-kB	NULL
u	NULL
“	NULL
u	NULL
u	NULL
-NF-kB	NULL
-n.s	NULL
-n.s	NULL
Figure	NULL
1	NULL
-	NULL
Ascorbate	NULL
Increases	NULL
TNF-	NULL
«	NULL
x-medlated	NULL
NF-xB	NULL
activation	NULL
Left	NULL
:	NULL
Jurkat	NULL
T-cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
P	NULL
;	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
1	NULL
;	NULL
0.5	NULL
gg/m	NULL
!	NULL
)	NULL

or	NULL
with	NULL
TNF-	NULL
«	NULL
(	NULL
TNF	NULL
,	NULL
;	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
60	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ascorbate	NULL
(	NULL
Asc	NULL
;	NULL
0.2	NULL
mM	NULL
)	NULL
.	NULL

Nucleoproteins	NULL
were	NULL
extracted	NULL
and	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
an	NULL
end-labelled	NULL
B	NULL
probe	NULL
.	NULL

Right	NULL
:	NULL
KBF	NULL
binding	NULL
of	NULL
proteins	NULL
from	NULL
TNF-	NULL
«	NULL
-plus-ascorbate-stimulated	NULL
cells	NULL
was	NULL
competed	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
oligonucleotide	NULL
IgkB	NULL
which	NULL
contains	NULL
the	NULL
NF-KB	NULL
motif	NULL
of	NULL
the	NULL
Ig	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
unrelated	NULL
oligonucleotides	NULL
SP1	NULL
and	NULL
AP-1	NULL
.	NULL

The	NULL
same	NULL
protein	NULL
extract	NULL
was	NULL
preincubated	NULL
either	NULL
with	NULL
anti-p50	NULL
antiserum	NULL
or	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
Pre	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabelled	NULL
KBF	NULL
probe	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/DNA	NULL
complex	NULL
is	NULL
indicated	NULL
{	NULL
n.s	NULL
.	NULL

,	NULL
non-specific	NULL
)	NULL
.	NULL

Ascorbate	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
25	NULL
Table	NULL
1	NULL
-	NULL
Effect	NULL
of	NULL
ascorbate	NULL
on	NULL
NF-xB	NULL
transcription	NULL
In	NULL
TNF-	NULL
«	NULL
-stlmulated	NULL
Jurkat	NULL
cells	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
NF-eB-dependent	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
KBF-Luc	NULL
and	NULL
HIV-LTR-Luc	NULL
or	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
mutant	NULL
of	NULL
HIV-LTR	NULL
(	NULL
mHIV-LTR-Luc	NULL
)	NULL
.	NULL

After	NULL
12	NULL
h	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

with	NULL
or	NULL
without	NULL
ascorbate	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
and	NULL
transcriptional	NULL
activity	NULL
expressed	NULL
as	NULL
xfold	NULL
transactivation	NULL
over	NULL
the	NULL
values	NULL
obtained	NULL
with	NULL
non-stimulated	NULL
cells	NULL
.	NULL

Values	NULL
are	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.01	NULL
compared	NULL
with	NULL
TNF-a	NULL
«	NULL
-stimulated	NULL
cells	NULL
.	NULL

Luciferase	NULL
activity	NULL
(	NULL
fold-induction	NULL
)	NULL
Plasmid	NULL
Treatment	NULL
transfected	NULL
...	NULL
-	NULL
KBF-Luc	NULL
HIV-LTR-Luc	NULL
mHIV-LTR-Luc	NULL
None	NULL
1	NULL
1	NULL
1	NULL
TNF-a	NULL
153+2	NULL
17425	NULL
1	NULL
TNF-	NULL
+	NULL
ascorbate	NULL
27	NULL
+3*	NULL
32+3.1*	NULL
1	NULL
Ascorbate	NULL
1	NULL
1	NULL
1	NULL
Table	NULL
2	NULL
-	NULL
Effect	NULL
of	NULL
ascorbate	NULL
on	NULL
TNF-x-	NULL
or	NULL
PMA-plus-lonomycin-stimulated	NULL
5.1	NULL
and	NULL
J-170	NULL
cells	NULL
5.1	NULL
and	NULL
J-170	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
TNF-	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
1	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ascorbate	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Results	NULL
are	NULL
means	NULL
+5.D	NULL
.	NULL

of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.001	NULL
compared	NULL
with	NULL
TNF-a-stimulated	NULL
5.1	NULL
cells	NULL
;	NULL
**P	NULL
<	NULL
0.25	NULL
(	NULL
not	NULL
significant	NULL
)	NULL
compared	NULL
with	NULL
PMA	NULL
-+	NULL
I-stimulated	NULL
5.1	NULL
cells	NULL
.	NULL

Fold-induction	NULL
Treatment	NULL
5.1	NULL
cells	NULL
J-170	NULL
cells	NULL
None	NULL
1	NULL
1	NULL
TNF-a	NULL
163+2	NULL
1	NULL
TNF-	NULL
+	NULL
ascorbate	NULL
29.3	NULL
+4*	NULL
1	NULL
PMA-+I	NULL
62+3	NULL
1	NULL
PMA	NULL
+I	NULL
+	NULL
ascorbate	NULL
41	NULL
+2**	NULL
1	NULL
Ascorbate	NULL
1	NULL
1	NULL
demonstrated	NULL
by	NULL
cold	NULL
competition	NULL
and	NULL
supershift	NULL
experiments	NULL
.	NULL

In	NULL
Figure	NULL
1	NULL
(	NULL
right	NULL
)	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
an	NULL
excess	NULL
(	NULL
50	NULL
x	NULL
)	NULL
of	NULL
cold	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
site	NULL
(	NULL
Ig	NULL
«	NULL
kB	NULL
)	NULL
,	NULL
but	NULL
not	NULL
of	NULL
SP1	NULL
or	NULL
AP-1	NULL
cold	NULL
oligo-nucleotides	NULL
,	NULL
competed	NULL
with	NULL
the	NULL
upper	NULL
complex	NULL
.	NULL

The	NULL
lower	NULL
complex	NULL
was	NULL
not	NULL
specifically	NULL
competed	NULL
by	NULL
the	NULL
three	NULL
cold	NULL
oligo-nucleotides	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
anti-p50	NULL
antiserum	NULL
but	NULL
not	NULL
the	NULL
preimmune	NULL
antiserum	NULL
prevented	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
DNA	NULL
.	NULL

Again	NULL
,	NULL
both	NULL
antisera	NULL
were	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
to	NULL
DNA	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
not	NULL
specific	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
also	NULL
reflected	NULL
by	NULL
increased	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transcriptional	NULL
activation	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
carrying	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
front	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
or	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1-LTR	NULL
followed	NULL
by	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
or	NULL
with	NULL
an	NULL
mHIV-LTR	NULL
plasmid	NULL
in	NULL
which	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
was	NULL
mutated	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
,	NULL
TNF-a	NULL
plus	NULL
ascorbate	NULL
,	NULL
or	NULL
ascorbate	NULL
alone	NULL
for	NULL
6	NULL
h	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
and	NULL
used	NULL
as	NULL
an	NULL
index	NULL
of	NULL
transactivation	NULL
.	NULL

Ascorbate	NULL
itself	NULL
was	NULL
not	NULL
able	NULL
to	NULL
induce	NULL
either	NULL
NF-	NULL
«	NULL
B-dependent	NULL
,	NULL
or	NULL
HIV-LTR	NULL
,	NULL
transactivation	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Notwithstanding	NULL
,	NULL
ascorbate	NULL
clearly	NULL
increased	NULL
NF-	NULL
«	NULL
B-mediated	NULL
HIV-LTR	NULL
transactivation	NULL
induced	NULL
by	NULL
TNF-a	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Results	NULL
obtained	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-Luc	NULL
plasmid	NULL
and	NULL
with	NULL
the	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
§	NULL
1§	NULL
30	NULL
60	NULL
120	NULL
TNF	NULL
‘	NULL
!	NULL

a-	NULL
s	NULL
ios	NULL
tad	NULL
Gund	NULL
Guat	NULL
-lkBqy	NULL
TNF	NULL
¥	NULL
+	NULL
5	NULL
Asc	NULL
~**	NULL
|	NULL
-lkBay	NULL
Ase	NULL
tee	NULL
cue	NULL
ms	NULL
tot	NULL
tad	NULL
cnet	NULL
|	NULL
-1KB	NULL
c	NULL
TNFa	NULL
TNFa+	NULL
Asc	NULL
Asc	NULL
Time	NULL
(	NULL
min	NULL
}	NULL
o	NULL
2	NULL
3	NULL
2	NULL
2	NULL
w	NULL
gg	NULL
§	NULL
a	NULL
o	NULL
g	NULL
8	NULL
®	NULL
Go	NULL
0e	NULL
On	NULL
+	NULL
_	NULL
@	NULL
CoG	NULL
Ce	NULL
.	NULL

a	NULL
on	NULL
Co	NULL
to	NULL
by	NULL
WP	NULL
bt	NULL
ins	NULL
Ch	NULL
tuh	NULL
bos	NULL
-	NULL
NF-kB	NULL
Figure	NULL
2	NULL
-	NULL
Effect	NULL
of	NULL
ascorbate	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
TNF-	NULL
«	NULL
-mediated	NULL
degradation	NULL
of	NULL
IkBx	NULL
and	NULL
NF-xB	NULL
binding	NULL
to	NULL
DNA	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-	NULL
(	NULL
TNF	NULL
,	NULL
;	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

TNF-a	NULL
plus	NULL
ascorbate	NULL
(	NULL
Asc	NULL
)	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
or	NULL
ascorbate	NULL
alone	NULL
.	NULL

At	NULL
the	NULL
times	NULL
indicated	NULL
cells	NULL
were	NULL
collected	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
cellular	NULL
extracts	NULL
and	NULL
analysed	NULL
for	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
a	NULL
)	NULL
and	NULL
for	NULL
DNA	NULL
binding	NULL
of	NULL
NF-B	NULL
by	NULL
EMSA	NULL
analysis	NULL
(	NULL
B	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
mutant	NULL
of	NULL
HIV-LTR	NULL
demonstrated	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
ascorbate	NULL
in	NULL
TNF-a	NULL
«	NULL
-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
specific	NULL
for	NULL
this	NULL
factor	NULL
.	NULL

We	NULL
then	NULL
used	NULL
5.1	NULL
cells	NULL
,	NULL
a	NULL
Jurkat-derived	NULL
clone	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-LTR	NULL
gene	NULL
in	NULL
front	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
as	NULL
another	NULL
approach	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
ascorbate	NULL
on	NULL
the	NULL
HIV-LTR	NULL
transcriptional	NULL
regulation	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
ascorbate	NULL
potentiated	NULL
TNF-	NULL
«	NULL
-induced	NULL
HIV-LTR	NULL
trans-activation	NULL
,	NULL
and	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activation	NULL
mediated	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

To	NULL
control	NULL
the	NULL
effect	NULL
of	NULL
ascorbate	NULL
on	NULL
luciferase	NULL
activity	NULL
,	NULL
a	NULL
Jurkat	NULL
cell	NULL
(	NULL
J-170	NULL
)	NULL
line	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
reported	NULL
by	NULL
the	NULL
CD11a	NULL
promoter	NULL
gene	NULL
was	NULL
stimulated	NULL
with	NULL
the	NULL
same	NULL
stimulus	NULL
that	NULL
was	NULL
used	NULL
for	NULL
5.1	NULL
cells	NULL
CD1lla	NULL
gene	NULL
promoter	NULL
was	NULL
not	NULL
transactivated	NULL
by	NULL
either	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
and	NULL
ascorbate	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
luciferase	NULL
activity	NULL
measured	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

As	NULL
was	NULL
described	NULL
above	NULL
,	NULL
binding	NULL
activity	NULL
detected	NULL
in	NULL
stimulated	NULL
cells	NULL
by	NULL
both	NULL
TNF-	NULL
«	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
correlated	NULL
with	NULL
the	NULL
transcriptional	NULL
activity	NULL
,	NULL
but	NULL
ascorbate	NULL
potentiation	NULL
was	NULL
specific	NULL
for	NULL
TNF-	NULL
«	NULL
-mediated	NULL
stimu-lation	NULL
.	NULL

Thus	NULL
the	NULL
action	NULL
of	NULL
ascorbate	NULL
in	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
appropriate	NULL
stimulus	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
26	NULL
E.	NULL
Mufoz	NULL
and	NULL
others	NULL
~ASC	NULL
+ASC	NULL
TNthUIﬂfml	NULL
)	NULL
:	NULL
0	NULL
1	NULL
10	NULL
50	NULL
1	NULL
10	NULL
50	NULL
Cis	NULL
cmm	NULL
coals	NULL
Tiss	NULL
«	NULL
_n	NULL
___	NULL
-	NULL
IkBa	NULL
won	NULL
cues	NULL
.	NULL

gore	NULL
que	NULL
wat	NULL
cmm	NULL
witt	NULL
|	NULL
-	NULL
DDO	NULL
Figure	NULL
3	NULL
-	NULL
Dose	NULL
Is	NULL
dependent	NULL
on	NULL
TNF-	NULL
«	NULL
-Induced	NULL
IxBa	NULL
degradation	NULL
In	NULL
Jurkat	NULL
cells	NULL
Jurkat	NULL
cells	NULL
(	NULL
0.5	NULL
x	NULL
10°/m	NULL
!	NULL
)	NULL

were	NULL
plated	NULL
in	NULL
35	NULL
mm	NULL
Petri	NULL
dishes	NULL
and	NULL
stimulated	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
TNF-a	NULL
(	NULL
TNF	NULL
,	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ascorbate	NULL
(	NULL
ASC	NULL
;	NULL
0.2	NULL
mM	NULL
)	NULL
.	NULL

After	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
cellular	NULL
extracts	NULL
,	NULL
and	NULL
analysed	NULL
for	NULL
IxBa	NULL
(	NULL
IB	NULL
,	NULL
)	NULL
and	NULL
p50	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

the	NULL
previous	NULL
concept	NULL
that	NULL
ascorbate	NULL
functions	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
growth	NULL
factors	NULL
[	NULL
26,27	NULL
]	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
always	NULL
preceded	NULL
by	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
inhibitory	NULL
«	NULL
B	NULL
proteins	NULL
[	NULL
14-16,24	NULL
]	NULL
.	NULL

Several	NULL
IB	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
and	NULL
two	NULL
major	NULL
species	NULL
,	NULL
IxBa	NULL
and	NULL
IxB	NULL
#	NULL
,	NULL
were	NULL
found	NULL
to	NULL
be	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
external	NULL
stimuli	NULL
[	NULL
24,28	NULL
]	NULL
,	NULL
but	NULL
only	NULL
IxBa	NULL
is	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
TNF-	NULL
«	NULL
[	NULL
28	NULL
]	NULL
.	NULL

Thus	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
ascorbate	NULL
on	NULL
IkBa	NULL
degradation	NULL
in	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
cytokine	NULL
induced	NULL
a	NULL
rapid	NULL
degradation	NULL
of	NULL
the	NULL
IxBa	NULL
«	NULL
protein	NULL
followed	NULL
by	NULL
its	NULL
recovery	NULL
which	NULL
was	NULL
completed	NULL
30-60	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

When	NULL
ascorbate	NULL
was	NULL
present	NULL
,	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
was	NULL
found	NULL
to	NULL
be	NULL
more	NULL
intense	NULL
and	NULL
its	NULL
recovery	NULL
delayed	NULL
,	NULL
and	NULL
protein	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
non-stimulated	NULL
cells	NULL
were	NULL
found	NULL
after	NULL
2	NULL
h	NULL
of	NULL
activation	NULL
.	NULL

The	NULL
more	NULL
persistent	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
TNF-a	NULL
plus	NULL
ascorbate-activated	NULL
cells	NULL
parallelled	NULL
with	NULL
an	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
DNA	NULL
through	NULL
time	NULL
(	NULL
Figure	NULL
2b	NULL
)	NULL
.	NULL

Ascorbate	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
IxBa	NULL
degradation	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
Figure	NULL
2b	NULL
)	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
transactivation	NULL
(	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
ascorbate	NULL
on	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
decreasing	NULL
doses	NULL
of	NULL
TNF-	NULL
«	NULL
was	NULL
also	NULL
studied	NULL
.	NULL

Western	NULL
blots	NULL
with	NULL
proteins	NULL
from	NULL
total	NULL
cell	NULL
extracts	NULL
showed	NULL
that	NULL
ascorbate	NULL
increased	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
mediated	NULL
by	NULL
TNF-a	NULL
,	NULL
even	NULL
at	NULL
the	NULL
lower	NULL
doses	NULL
tested	NULL
.	NULL

When	NULL
the	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
an	NULL
anti-p50	NULL
antiserum	NULL
it	NULL
was	NULL
found	NULL
that	NULL
the	NULL
steady-state	NULL
levels	NULL
for	NULL
p50	NULL
protein	NULL
remained	NULL
unchanged	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
HIV-LTR	NULL
induced	NULL
by	NULL
TNF-a	NULL
in	NULL
5.1	NULL
cells	NULL
was	NULL
also	NULL
increased	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
ascorbate	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Physiologically	NULL
,	NULL
this	NULL
may	NULL
be	NULL
relevant	NULL
since	NULL
the	NULL
concentration	NULL
of	NULL
TNF-	NULL
«	NULL
may	NULL
vary	NULL
in	NULL
the	NULL
different	NULL
sites	NULL
of	NULL
the	NULL
organism	NULL
,	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
this	NULL
cytokine	NULL
may	NULL
be	NULL
greatly	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
ascorbate	NULL
.	NULL

To	NULL
shed	NULL
light	NULL
on	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
ascorbate	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
with	NULL
TNF-a	NULL
@	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ascorbate	NULL
,	NULL
AFR	NULL
or	NULL
DHA	NULL
for	NULL
60	NULL
min	NULL
.	NULL

We	NULL
found	NULL
that	NULL
AFR	NULL
behaved	NULL
similarly	NULL
to	NULL
ascorbate	NULL
in	NULL
increasing	NULL
Table	NULL
3	NULL
-	NULL
Effect	NULL
of	NULL
TNF-x	NULL
on	NULL
ascorbate-treated	NULL
5.1	NULL
cells	NULL
5.1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
ascorbate	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
TNF-	NULL
«	NULL
for	NULL
6h	NULL
.	NULL

Results	NULL
are	NULL
means	NULL
+S.0	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Index	NULL
of	NULL
transactivation	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
between	NULL
luciferase	NULL
activity	NULL
detected	NULL
in	NULL
stimulated	NULL
versus	NULL
non-stimulated	NULL
cells	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
compared	NULL
with	NULL
TNF-a-stimulated	NULL
5.1	NULL
cells	NULL
;	NULL
ns	NULL
,	NULL
not	NULL
significant	NULL
.	NULL

Treatment	NULL
Index	NULL
of	NULL
transactivation	NULL
None	NULL
1	NULL
TNF-	NULL
«	NULL
{	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

102+2	NULL
TNF-	NULL
«	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

123+3	NULL
TNF-a	NULL
{	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

1545	NULL
TNF-a	NULL
{	NULL
1	NULL
ng/ml	NULL
)	NULL
+	NULL
ascorbate	NULL
144+4	NULL
(	NULL
ng	NULL
)	NULL
``	NULL
TNF-a	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

+	NULL
ascorbate	NULL
24.3	NULL
+2*	NULL
TNF-a	NULL
{	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

+	NULL
ascorbate	NULL
29.2	NULL
+2*	NULL
TNFy+	NULL
Ase	NULL
TNF	NULL
TNF	NULL
,	NULL
,	NULL
+	NULL
AFR	NULL
TNFy+	NULL
DHA	NULL
Cap	NULL
p50	NULL
+	NULL
Iub	NULL
WW	NULL
]	NULL
-	NULL
NF-KB	NULL
Figure	NULL
4	NULL
-	NULL
AFR	NULL
but	NULL
not	NULL
DHA	NULL
Increases	NULL
both	NULL
IkBx	NULL
degradation	NULL
and	NULL
NF-xB	NULL
binding	NULL
In	NULL
TNF-	NULL
«	NULL
-stlmulated	NULL
Jurkat	NULL
cells	NULL
Cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
TNF	NULL
,	NULL
,	NULL
;	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
ascorbate	NULL
(	NULL
Asc	NULL
)	NULL
,	NULL
AFR	NULL
or	NULL
DHA	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
1	NULL
h	NULL
,	NULL
total	NULL
cellular	NULL
extracts	NULL
were	NULL
analysed	NULL
for	NULL
(	NULL
IB	NULL
,	NULL
)	NULL
and	NULL
p50	NULL
protein	NULL
expression	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
DNA	NULL
as	NULL
indicated	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

IkxBa	NULL
«	NULL
degradation	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
TNF-	NULL
«	NULL
-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
DHA	NULL
(	NULL
the	NULL
fully	NULL
oxidized	NULL
form	NULL
of	NULL
ascorbate	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
TNF-	NULL
«	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
with	NULL
Ascorbate	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
27	NULL
Table	NULL
4	NULL
-	NULL
Effect	NULL
of	NULL
ascorbate	NULL
,	NULL
ascorbate	NULL
phosphate	NULL
(	NULL
ASC-P	NULL
)	NULL
,	NULL
AFR	NULL
,	NULL
DHA	NULL
and	NULL
Imidazole	NULL
(	NULL
1	NULL
)	NULL
on	NULL
HIV-LTR	NULL
transcription	NULL
In	NULL
TNF-	NULL
«	NULL
-stlmulated	NULL
5.1	NULL
cells	NULL
5.1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
ascorbate	NULL
,	NULL
ASC-P	NULL
,	NULL
AFR	NULL
,	NULL
DHA	NULL
and	NULL
|	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
,	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
6	NULL
h	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

Index	NULL
of	NULL
transactivation	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
between	NULL
luciferase	NULL
activity	NULL
detected	NULL
in	NULL
stimulated	NULL
and	NULL
non-stimulated	NULL
cells	NULL
.	NULL

Results	NULL
are	NULL
means	NULL
+S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

*Compared	NULL
with	NULL
TNF-	NULL
«	NULL
-	NULL
or	NULL
TNF-	NULL
«	NULL
-plus-ASC-P-stimulated	NULL
cells	NULL
;	NULL
**compared	NULL
with	NULL
TNF-a-stimulated	NULL
cells	NULL
(	NULL
ns	NULL
,	NULL
not	NULL
signifi-cant	NULL
)	NULL
.	NULL

Treatment	NULL
Index	NULL
of	NULL
transactivation	NULL
None	NULL
1	NULL
TNF-a	NULL
14.1	NULL
+3	NULL
TNF-a	NULL
+	NULL
ascorbate	NULL
(	NULL
0.025	NULL
mM	NULL
)	NULL
TNF-a	NULL
+	NULL
ascorbate	NULL
(	NULL
0.05	NULL
mM	NULL
)	NULL
TNF-a	NULL
+	NULL
ascorbate	NULL
(	NULL
0.1	NULL
mM	NULL
)	NULL
TNF-a	NULL
+	NULL
ascorbate	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
203+3	NULL
P	NULL
<	NULL
0.05*	NULL
226	NULL
+2	NULL
P	NULL
<	NULL
0.05*	NULL
25.7	NULL
+2	NULL
P	NULL
<	NULL
0.05°	NULL
28.5	NULL
+5	NULL
P	NULL
<	NULL
0.05*	NULL
TNF-a	NULL
+	NULL
ASC-P	NULL
(	NULL
0.025	NULL
mM	NULL
)	NULL
15.5	NULL
+4	NULL
ns**	NULL
TNF-a	NULL
+	NULL
ASC-P	NULL
(	NULL
0.05	NULL
mM	NULL
)	NULL
14.1	NULL
+3	NULL
ns**	NULL
TNF-a	NULL
+	NULL
ASC-P	NULL
(	NULL
0.1	NULL
mM	NULL
)	NULL
15.2	NULL
+2	NULL
ns**	NULL
TNF-a	NULL
+	NULL
ASC-P	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
17	NULL
+4	NULL
ns**	NULL
TNF-a	NULL
+	NULL
AFR	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
31.5+3	NULL
P	NULL
<	NULL
0.05*	NULL
TNF-a	NULL
+	NULL
DHA	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
15.2	NULL
+3	NULL
ns**	NULL
TNFa	NULL
+1	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
14.3	NULL
+3	NULL
ns**	NULL
transactivating	NULL
experiments	NULL
in	NULL
5.1	NULL
cells	NULL
(	NULL
Table	NULL
4	NULL
)	NULL
,	NULL
where	NULL
TNF-	NULL
«	NULL
-mediated	NULL
HIV-LTR	NULL
transcription	NULL
was	NULL
significantly	NULL
increased	NULL
by	NULL
ascorbate	NULL
and	NULL
AFR	NULL
.	NULL

This	NULL
increase	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
DHA	NULL
or	NULL
1	NULL
mM	NULL
imidazole	NULL
(	NULL
maximal	NULL
concentration	NULL
contained	NULL
in	NULL
the	NULL
AFR	NULL
preparation	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
HIV-LTR	NULL
transactivation	NULL
in	NULL
TNF-a-stimulated	NULL
5.1	NULL
cells	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
ascorbate	NULL
phosphate	NULL
,	NULL
a	NULL
form	NULL
of	NULL
ascorbate	NULL
that	NULL
can	NULL
not	NULL
be	NULL
oxidized	NULL
(	NULL
Table	NULL
4	NULL
)	NULL
[	NULL
29	NULL
]	NULL
.	NULL

Thus	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
apparent	NULL
activity	NULL
of	NULL
ascorbate	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
generation	NULL
of	NULL
AFR	NULL
,	NULL
the	NULL
first	NULL
product	NULL
of	NULL
its	NULL
oxidation	NULL
[	NULL
2	NULL
]	NULL
,	NULL
and	NULL
it	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
production	NULL
of	NULL
superoxide	NULL
since	NULL
exogenously	NULL
added	NULL
superoxide	NULL
dismutase	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
action	NULL
of	NULL
ascorbate	NULL
or	NULL
AFR	NULL
on	NULL
HIV-LTR	NULL
transcription	NULL
in	NULL
TNF-w-activated	NULL
5.1	NULL
cells	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
ascorbate	NULL
action	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
growth	NULL
of	NULL
different	NULL
cells	NULL
in	NULL
vitro	NULL
is	NULL
also	NULL
carried	NULL
out	NULL
by	NULL
its	NULL
free	NULL
radical	NULL
but	NULL
not	NULL
by	NULL
superoxide	NULL
generation	NULL
[	NULL
11,27	NULL
]	NULL
.	NULL

The	NULL
current	NULL
concept	NULL
is	NULL
that	NULL
IxBa	NULL
is	NULL
phosphorylated	NULL
at	NULL
serine	NULL
residues	NULL
32	NULL
and	NULL
36	NULL
by	NULL
an	NULL
ubiquitinated	NULL
IxB	NULL
kinase	NULL
.	NULL

After	NULL
phosphorylation	NULL
,	NULL
IxBa	NULL
is	NULL
ubiquitinated	NULL
on	NULL
lysine	NULL
residues	NULL
and	NULL
then	NULL
degraded	NULL
by	NULL
the	NULL
ubiquitin	NULL
proteasome	NULL
pathway	NULL
[	NULL
23,30,31	NULL
]	NULL
.	NULL

Several	NULL
possibilities	NULL
exist	NULL
to	NULL
explain	NULL
the	NULL
role	NULL
of	NULL
ascorbate	NULL
and	NULL
its	NULL
free	NULL
radical	NULL
on	NULL
the	NULL
IxBa	NULL
degradation	NULL
mediated	NULL
by	NULL
TNF-	NULL
«	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Ascorbate	NULL
and	NULL
AFR	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
ubiquitination	NULL
of	NULL
either	NULL
the	NULL
IB	NULL
kinase	NULL
or	NULL
the	NULL
IxBa	NULL
protein	NULL
mediated	NULL
by	NULL
TNF-x	NULL
.	NULL

Mild	NULL
oxidation	NULL
of	NULL
RNase	NULL
A	NULL
protein	NULL
renders	NULL
it	NULL
more	NULL
susceptible	NULL
to	NULL
ubiquitination	NULL
[	NULL
32	NULL
]	NULL
.	NULL

However	NULL
,	NULL
these	NULL
compounds	NULL
could	NULL
increase	NULL
the	NULL
catalytic	NULL
activity	NULL
of	NULL
the	NULL
IxB	NULL
kinase	NULL
or	NULL
could	NULL
inhibit	NULL
some	NULL
serine	NULL
phosphatase	NULL
involved	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signalling	NULL
pathway	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
IkBa	NULL
phosphorylation	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
balance	NULL
between	NULL
kinase	NULL
and	NULL
phosphatase	NULL
activities	NULL
[	NULL
21,33	NULL
]	NULL
.	NULL

The	NULL
putative	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
involved	NULL
in	NULL
IxBa	NULL
phosphorylation	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
and	NULL
whether	NULL
it	NULL
may	NULL
be	NULL
inhibited	NULL
by	NULL
ascorbate	NULL
remains	NULL
to	NULL
be	NULL
studied	NULL
.	NULL

AFR	NULL
is	NULL
the	NULL
substrate	NULL
for	NULL
the	NULL
NADH-dependent	NULL
trans-plasma	NULL
membrane	NULL
electron	NULL
transport	NULL
of	NULL
mammalian	NULL
cells	NULL
[	NULL
3,5	NULL
]	NULL
,	NULL
and	NULL
its	NULL
activation	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
induces	NULL
changes	NULL
to	NULL
a	NULL
more	NULL
oxidative	NULL
state	NULL
of	NULL
cytosol	NULL
by	NULL
increasing	NULL
oxidized	NULL
pyridine	NULL
nucleotides	NULL
[	NULL
11	NULL
]	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
this	NULL
redox	NULL
system	NULL
may	NULL
modulate	NULL
the	NULL
cytoplasmic	NULL
60	NULL
i-2	NULL
50	NULL
H-Thymidine	NULL
incorporation	NULL
(	NULL
dpm/10®	NULL
cells	NULL
)	NULL
(	NULL
x10	NULL
*	NULL
)	NULL
1	NULL
3	NULL
1	NULL
40	NULL
0	NULL
1	NULL
10	NULL
25	NULL
50	NULL
TNF	NULL
,	NULL
,	NULL
(	NULL
ng/ml	NULL
)	NULL
Figure	NULL
5	NULL
-	NULL
Effect	NULL
of	NULL
ascorbate	NULL
on	NULL
TNF-x-Induced	NULL
growth	NULL
Inhibition	NULL
Jurkat	NULL
T-cells	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
doses	NULL
of	NULL
TNF-	NULL
(	NULL
TNF	NULL
,	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
@	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
O	NULL
)	NULL
of	NULL
ascorbate	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
.	NULL

DNA	NULL
synthesis	NULL
was	NULL
measured	NULL
by	NULL
H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
for	NULL
the	NULL
last	NULL
6	NULL
h	NULL
of	NULL
the	NULL
48-h	NULL
culture	NULL
period	NULL
.	NULL

Mean	NULL
values	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
triplicate	NULL
samples	NULL
are	NULL
given	NULL
.	NULL

P	NULL
<	NULL
0.05	NULL
for	NULL
all	NULL
concentrations	NULL
of	NULL
TNF-	NULL
when	NULL
compared	NULL
with	NULL
TNF-	NULL
plus	NULL
ascorbate-stimulated	NULL
cells	NULL
.	NULL

redox	NULL
equilibrium	NULL
[	NULL
34	NULL
]	NULL
and	NULL
induce	NULL
changes	NULL
in	NULL
the	NULL
conformation	NULL
of	NULL
transcription	NULL
factors	NULL
[	NULL
35	NULL
]	NULL
.	NULL

Then	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
ascorbate	NULL
action	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
involves	NULL
changes	NULL
in	NULL
the	NULL
signalling	NULL
pathways	NULL
used	NULL
by	NULL
TNF-a	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
probably	NULL
starting	NULL
at	NULL
the	NULL
receptor	NULL
itself	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
ascorbate	NULL
can	NULL
mediate	NULL
the	NULL
activation	NULL
of	NULL
latent	NULL
transforming	NULL
growth	NULL
factor-	NULL
#	NULL
1	NULL
receptor	NULL
[	NULL
36	NULL
]	NULL
.	NULL

TNF-a	NULL
is	NULL
cytotoxic	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
by	NULL
increasing	NULL
the	NULL
intracellular	NULL
oxidative	NULL
status	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
other	NULL
T-cells	NULL
,	NULL
TNF-a	NULL
«	NULL
is	NULL
not	NULL
cytotoxic	NULL
but	NULL
inhibits	NULL
cell	NULL
growth	NULL
[	NULL
37	NULL
]	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
ascorbate	NULL
in	NULL
TNF-a-mediated	NULL
arrested	NULL
growth	NULL
of	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
incorporation	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ascorbate	NULL
(	NULL
0.2	NULL
mM	NULL
)	NULL
at	NULL
different	NULL
concentrations	NULL
of	NULL
TNF-x	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
that	NULL
ascorbate	NULL
itself	NULL
does	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
growth	NULL
of	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
increases	NULL
growth	NULL
inhibition	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
all	NULL
the	NULL
doses	NULL
of	NULL
TNF-	NULL
«	NULL
.	NULL

This	NULL
enhanced	NULL
inhibition	NULL
of	NULL
cell	NULL
growth	NULL
correlated	NULL
with	NULL
the	NULL
changes	NULL
observed	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
results	NULL
demonstrate	NULL
that	NULL
in	NULL
TNF-a-stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
ascorbate	NULL
and	NULL
its	NULL
free	NULL
radical	NULL
potentiate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
this	NULL
effect	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
accelerated	NULL
rate	NULL
of	NULL
IxBa	NULL
degradation	NULL
.	NULL

Redox	NULL
modulation	NULL
of	NULL
cell	NULL
nutrients	NULL
due	NULL
to	NULL
plasma-membrane-acting	NULL
factors	NULL
or	NULL
stress-induced	NULL
responses	NULL
may	NULL
induce	NULL
changes	NULL
in	NULL
cell	NULL
signalling	NULL
or	NULL
protein	NULL
conformation	NULL
that	NULL
could	NULL
count	NULL
as	NULL
an	NULL
important	NULL
mechanism	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
SAF	NULL
95/0474	NULL
and	NULL
BP	NULL
95/560	NULL
from	NULL
CICYT	NULL
(	NULL
Ministerio	NULL
de	NULL
Educacidn	NULL
y	NULL
Ciencia	NULL
)	NULL
to	NULL
E.	NULL
M.	NULL
and	NULL
P.	NULL
N.	NULL
respectively	NULL
.	NULL

M.	NULL
V.	NULL
B.	NULL
is	NULL
a	NULL
fellow	NULL
from	NULL
Fundacion	NULL
Cajasur-Reina	NULL
Soffa	NULL
(	NULL
Cordoba	NULL
,	NULL
Spain	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

N.	NULL
Isragl	NULL
and	NULL
A.	NULL
Garcia	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
for	NULL
the	NULL
5.1	NULL
cell	NULL
ling	NULL
and	NULL
for	NULL
the	NULL
HIV-LTR	NULL
plasmids	NULL
,	NULL
Dr.	NULL
A.	NULL
Corbi	NULL
(	NULL
C.S.1.C	NULL
.	NULL

,	NULL
Granada	NULL
,	NULL
Spain	NULL
)	NULL
for	NULL
the	NULL
J-170	NULL
cell	NULL
ling	NULL
,	NULL
Drs	NULL
.	NULL

R.	NULL
T.	NULL
Hay	NULL
and	NULL
K.	NULL
Wood	NULL
(	NULL
University	NULL
of	NULL
St.	NULL
Andrews	NULL
,	NULL
Scotland	NULL
)	NULL
for	NULL
the	NULL
monoclonal	NULL
antibody	NULL
108	NULL
,	NULL
Dr.	NULL
A.	NULL
Isragl	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
for	NULL
the	NULL
anti-p50	NULL
antiserum	NULL
and	NULL
Esteban	NULL
Tarradas	NULL
for	NULL
the	NULL
photographic	NULL
work	NULL
.	NULL

28	NULL
E.	NULL
Mufoz	NULL
and	NULL
others	NULL
REFERENCES	NULL
18	NULL
-	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rigber	NULL
,	NULL
P.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
19	NULL
-	NULL
Meyer	NULL
,	NULL
M.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
and	NULL
Basuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2005-2015	NULL
1	NULL
-	NULL
Crang	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
Sun	NULL
,	NULL
1	NULL
.	NULL

L.	NULL
,	NULL
Clark	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Grebing	NULL
,	NULL
C.	NULL
and	NULL
Low	NULL
,	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Biochim	NULL
.	NULL

20	NULL
-	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Mittier	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Nadler	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Kirihara	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Kanner	NULL
,	NULL
Biophys	NULL
.	NULL

Acta	NULL
811	NULL
,	NULL
233-264	NULL
S.	NULL
B.	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

299	NULL
,	NULL
20718-20726	NULL
2	NULL
Beyer	NULL
,	NULL
R.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biognerg	NULL
.	NULL

Biomembr	NULL
.	NULL

26	NULL
,	NULL
349-358	NULL
21	NULL
-	NULL
Traenckner	NULL
,	NULL
E	NULL
.	NULL

BM	NULL
.	NULL

,	NULL
Wilk	NULL
,	NULL
S.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5433-5441	NULL
3	NULL
-	NULL
Villalba	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Navarro	NULL
,	NULL
F.	NULL
,	NULL
Cordoba	NULL
,	NULL
F.	NULL
,	NULL
Serrano	NULL
,	NULL
A.	NULL
,	NULL
Crang	NULL
,	NULL
F.	NULL
L.	NULL
and	NULL
Navas	NULL
,	NULL
P.	NULL
22	NULL
-	NULL
Alkalay	NULL
,	NULL
|	NULL
.	NULL

,	NULL
Yaron	NULL
,	NULL
A.	NULL
,	NULL
Hatzubai	NULL
,	NULL
A.	NULL
,	NULL
Orian	NULL
,	NULL
A.	NULL
,	NULL
Ciechanover	NULL
,	NULL
A.	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
92	NULL
,	NULL
4887-4891	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
92	NULL
,	NULL
10599-10603	NULL
4	NULL
-	NULL
Pething	NULL
,	NULL
R.	NULL
,	NULL
Gascoyne	NULL
,	NULL
P.	NULL
R.	NULL
C.	NULL
,	NULL
McLaughlin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
and	NULL
Szent-Gy6rgy	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
23	NULL
-	NULL
Chen	NULL
,	NULL
J	NULL
.	NULL

Z.	NULL
,	NULL
Parent	NULL
,	NULL
L.	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
853-862	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
82	NULL
,	NULL
1439-1442	NULL
24	NULL
-	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
1.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Herigh	NULL
,	NULL
Y.	NULL
and	NULL
Baguerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

5	NULL
-	NULL
Gomez-Diaz	NULL
,	NULL
C.	NULL
,	NULL
Rodriguez-Aguilera	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Barroso	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Villalba	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Navarro	NULL
,	NULL
F.	NULL
,	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
182-185	NULL
Crane	NULL
,	NULL
F.	NULL
L.	NULL
and	NULL
Navas	NULL
,	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biognerg	NULL
.	NULL

Biomembr	NULL
.	NULL

,	NULL
in	NULL
the	NULL
press	NULL
25	NULL
-	NULL
Alcain	NULL
,	NULL
F.	NULL
J.	NULL
and	NULL
Burdon	NULL
,	NULL
M.	NULL
1	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Bicgnerg	NULL
.	NULL

Biomembr	NULL
.	NULL

26	NULL
,	NULL
393-398	NULL
6	NULL
-	NULL
Alcain	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Burdon	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Villalba	NULL
,	NULL
J.	NULL
M.	NULL
and	NULL
Navas	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

26	NULL
-	NULL
Navas	NULL
,	NULL
P.	NULL
,	NULL
Alcain	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Burén	NULL
,	NULL
1.	NULL
,	NULL
Rodriguez	NULL
Aguilera	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Villalba	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Morré	NULL
,	NULL
Acta	NULL
1073	NULL
,	NULL
380-385	NULL
D.	NULL
M.	NULL
and	NULL
Morré	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

209	NULL
,	NULL
223-226	NULL
7	NULL
-	NULL
Minetti	NULL
,	NULL
M.	NULL
,	NULL
Forte	NULL
,	NULL
T.	NULL
,	NULL
Soriani	NULL
,	NULL
M.	NULL
,	NULL
Quaresima	NULL
,	NULL
V.	NULL
,	NULL
Menditto	NULL
,	NULL
A.	NULL
and	NULL
Ferrari	NULL
,	NULL
M.	NULL
27	NULL
-	NULL
Navas	NULL
,	NULL
P.	NULL
,	NULL
Villalba	NULL
,	NULL
J.	NULL
M.	NULL
and	NULL
Cordoba	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1197	NULL
,	NULL
1-13	NULL
(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

282	NULL
,	NULL
459-465	NULL
28	NULL
-	NULL
Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Phillips	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Erdjument-Bromage	NULL
,	NULL
H.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
and	NULL
Ghosh	NULL
,	NULL
S.	NULL
8	NULL
-	NULL
Harris	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

(	NULL
1996	NULL
)	NULL
Subcellular	NULL
Biochemistry	NULL
,	NULL
vol	NULL
.	NULL

25	NULL
,	NULL
p.	NULL
57	NULL
,	NULL
Plenum	NULL
Press	NULL
,	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
573-582	NULL
New	NULL
York	NULL
29	NULL
-	NULL
Hata	NULL
,	NULL
R-	NULL
.	NULL

and	NULL
Senoo	NULL
,	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

138	NULL
,	NULL
8-16	NULL
9	NULL
-	NULL
Harris	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

(	NULL
1996	NULL
)	NULL
Subcellular	NULL
Biochemistry	NULL
,	NULL
vol	NULL
.	NULL

25	NULL
,	NULL
p.	NULL
83	NULL
,	NULL
Plenum	NULL
Press	NULL
,	NULL
30	NULL
-	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Gerstberger	NULL
,	NULL
S.	NULL
,	NULL
Carlson	NULL
,	NULL
L.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
and	NULL
Sigbenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
New	NULL
York	NULL
Science	NULL
247	NULL
,	NULL
1485-1491	NULL
10	NULL
-	NULL
Anderson	NULL
,	NULL
R.	NULL
,	NULL
Oosthuizen	NULL
,	NULL
R.	NULL
,	NULL
Maritz	NULL
,	NULL
R.	NULL
,	NULL
Theron	NULL
,	NULL
A.	NULL
and	NULL
van	NULL
Rensbur	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
31	NULL
-	NULL
Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chen	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
and	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Nutr	NULL
.	NULL

33	NULL
,	NULL
71-76	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
92	NULL
,	NULL
11259-11263	NULL
11	NULL
-	NULL
Alcain	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Buron	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Rodriguez-Aguilera	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Villalba	NULL
,	NULL
J.	NULL
M.	NULL
and	NULL
Navas	NULL
,	NULL
P.	NULL
32	NULL
-	NULL
Hershko	NULL
,	NULL
A.	NULL
,	NULL
Heller	NULL
,	NULL
H.	NULL
,	NULL
Eytan	NULL
,	NULL
E.	NULL
and	NULL
Reiss	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261	NULL
,	NULL
(	NULL
1990	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

50	NULL
,	NULL
5887-5891	NULL
11992-11999	NULL
12	NULL
-	NULL
De	NULL
Laurenzi	NULL
,	NULL
V.	NULL
,	NULL
Melino	NULL
,	NULL
G.	NULL
,	NULL
Savini	NULL
,	NULL
I.	NULL
,	NULL
Annicchiarico-Petruzelli	NULL
,	NULL
M.	NULL
,	NULL
Finazzi-Agrd	NULL
,	NULL
A	NULL
.	NULL

33	NULL
-	NULL
Menon	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Qin	NULL
,	NULL
S.	NULL
,	NULL
Guy	NULL
,	NULL
G.	NULL
R.	NULL
and	NULL
Tan	NULL
,	NULL
Y.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
and	NULL
Avigliano	NULL
,	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
4	NULL
,	NULL
463-466	NULL
26805-26812	NULL
13	NULL
-	NULL
Sen	NULL
,	NULL
R.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
705-714	NULL
34	NULL
-	NULL
Crane	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
Morré	NULL
,	NULL
J.	NULL
and	NULL
Lw	NULL
,	NULL
H.	NULL
E	NULL
.	NULL

(	NULL
eds	NULL
.	NULL
)	NULL

(	NULL
1993	NULL
)	NULL
Oxidoreduction	NULL
at	NULL
the	NULL
Plasma	NULL
14	NULL
-	NULL
Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.	NULL
J.	NULL
S.	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143	NULL
,	NULL
1-62	NULL
Membrane	NULL
:	NULL
Relation	NULL
to	NULL
Growth	NULL
and	NULL
Transport	NULL
,	NULL
p.	NULL
225	NULL
,	NULL
CRC	NULL
Press	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
FL	NULL
15	NULL
-	NULL
Finco	NULL
,	NULL
T.	NULL
S.	NULL
and	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
3	NULL
,	NULL
263-272	NULL
35	NULL
-	NULL
Hainaut	NULL
,	NULL
P.	NULL
and	NULL
Milner	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

53	NULL
,	NULL
4469-4473	NULL
16	NULL
-	NULL
Verma	NULL
,	NULL
1	NULL
.	NULL

M.	NULL
,	NULL
Stevenson	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Schwarz	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
and	NULL
Miyamoto	NULL
,	NULL
S.	NULL
36	NULL
-	NULL
Barcellos-Hoff	NULL
,	NULL
M.	NULL
H.	NULL
and	NULL
Dix	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

10	NULL
,	NULL
1077-1083	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
2723-2735	NULL
37	NULL
-	NULL
Westendorf	NULL
,	NULL
M.	NULL
0.	NULL
,	NULL
Shatrov	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Frank	NULL
,	NULL
R.	NULL
,	NULL
Kraft	NULL
,	NULL
M.	NULL
,	NULL
Los	NULL
,	NULL
M.	NULL
,	NULL
17	NULL
-	NULL
Isrdel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

11	NULL
,	NULL
203-205	NULL
Krammer	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Drige	NULL
,	NULL
W.	NULL
and	NULL
Lehmann	NULL
,	NULL
V.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
546-554	NULL
Received	NULL
20	NULL
September	NULL
1996/20	NULL
February	NULL
1997	NULL
;	NULL
accepted	NULL
5	NULL
March	NULL
1997	NULL

